Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by somweyungguyon Oct 12, 2016 5:24pm
132 Views
Post# 25336980

The BNN newsflash with updated "analyst targets"

The BNN newsflash with updated "analyst targets"I'm starting to wonder if what exactly is "going on"??

How "helpful" is a 4 CENT share price target, it is one CENT less helpful than the other financing partners 5 CENT target.

Why doesn't Spectral politely ask them to "DROP COVERAGE"

In the case of Cormark and their "analysis", they has us UNDER REVIEW for 360 DAYS from June 4th 2015 to May 30th 2016 ( did NOT wait for AGM on May 31st )  Their May 30th paper also allowed for a miss on the COMPASSIONATE CARE approval.

Time to cut the BS and get down to exactly what is going on here

Too many people lined up to take 4 CENT stock in the mid 30's ALL DAY LONG!

Sqr
Bullboard Posts